VANCOUVER, British Columbia, Nov. 4, 2019 /CNW/ -- Sunniva Inc. ("Sunniva", the "Company", "we", "our" or "us") (CSE:SNN) (OTCQB:SNNVF), a North American provider of cannabis products and services, announces Dave Lyle, Chief Financial Officer has resigned as an officer, effective November 1st, for personal reasons.

(PRNewsfoto/Sunniva Inc.)

The Company's Global Controller, David Weinmann, has been appointed to Interim CFO. Mr. Weinmann has a Bachelor of Science in Accountancy from San Diego State University. David has over 20 years of progressively increasing experience in both public and privately held companies with the majority of his career in the biotech and pharmaceutical industries. Prior to joining Sunniva, he worked for Thermo Fisher Scientific, Inc., Accriva Diagnostics, and Ambit Biosciences.  He has spent the past few years consulting for companies within the start up, transition, and transaction phase, this includes, ACEA Biosciences, Inc., Ametek, Inc., and Robo3D Limited.

"On behalf of the Board of Directors and our employees, I would like to thank Dave Lyle for his contributions to Sunniva," said CEO Anthony Holler. "David Weinmann has been an integral part of the building of the Finance group California and overseeing the development and implementation of the financial planning and accounting functions as we transitioned to the Carlsbad office. With Mr. Weinmann's outstanding leadership skills and his finance and accounting experience supported by the team Sunniva has built over the past six months we have every confidence in David's ability to succeed in this role."

For more information please visit:

To be added to the Sunniva email distribution list please register at

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

About Sunniva, Inc.

Sunniva, through its subsidiaries, is building a vertically integrated cannabis company operating in two of the world's largest legal cannabis markets – California and Canada.  In Canada, Sunniva's wholly owned subsidiary Natural Health Services Ltd. operates medical cannabis clinics that provide educational and clinical services to patients. In California, Sunniva is constructing a 325,000 square foot, purpose-built cGMP designed greenhouse for cannabis cultivation and operates a fully licensed cannabis extraction facility, in-house marketing and licensed cannabis distribution businesses.

Cautionary Note Regarding Forward-Looking Information or Statements

This press release contains forward-looking information or statements. All statements that are or information which is not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, statements regarding, Sunniva's focus on creating premium cannabis brands, , and Sunniva's positioning in California as a leading provider of safe, high quality, reproducible products at scale, are "forward-looking information or statements".  Forward-looking information or statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. With respect to forward-looking information and statements contained herein, Sunniva has made numerous assumptions including, among other things, assumptions about general business and economic conditions and assumptions that Sunniva's infrastructure in California will allow it to create sustainable premium cannabis brands. Such forward-looking statements are based on assumptions and involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking information or statements. Such risks and uncertainties include, among others, the risk factors included in the Sunniva's continuous disclosure documents available on These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking information or statements. Although Sunniva has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking information or statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking information or statements. Sunniva assumes no obligation to update any forward-looking information or statements, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.

Company Contacts:

Sunniva Inc.                                                     

Investor Relations Contact    

Dr. Anthony Holler                                                  

Rob Knowles 

Chairman and Chief Executive Officer                     

VP Corporate Development

Phone: (866) 786-6482                                              

Phone: (587) 430-0680



Cision View original content to download multimedia:

SOURCE Sunniva Inc.